Additionally, interferon signaling in B-cells was elevated in patients without pulmonary injury, indicated by increased expression of MX130, XAF131, and IFI44L compared to patients with pneumonic COVID-19 (Fig. 2e, f). Here, IFI44L is linked to COVID-19.